AlphaMedix Shows Strong Results in GEP-NETs Phase 2 Trial

AlphaMedix (212Pb-DOTAMTATE), an investigational somatostatin receptor (SSTR)-targeted alpha therapy using the lead-212 isotope, met all primary efficacy endpoints and demonstrated clinically meaningful overall response rates (ORR) and prolonged

Shukra Pharma Gets Nod for Robotic Surgery Projects

Shukra Pharmaceuticals has made a remarkable step to enter the world of cutting-edge medical technology by obtaining official approval from Meril Healthcare for robotic surgery projects

Enzene Partners with Virtuosi to Advance Biologics Workforce

Enzene Biosciences Ltd., a premier Continuously Innovative Development and Manufacturing Organization (CIDMO) for biologics, has entered the immersive learning space by partnering with Virtuosi. Virtuosi have been developed by Quality Executive...

NephroPlus Crosses 500 Clinics, Opens New Unit in Saharanpur

According to the Frost & Sullivan Report 2025, NephroPlus, the largest dialysis service provider in Asia, has crossed a major milestone of over 500 dialysis centers across the globe. Marking this achievement, the company announced the launch...

AstraZeneca India Gains Approval for Solid Tumor Therapy

For a second indication, UK pharmaceutical giant AstraZeneca India has obtained expanded approval for its cancer treatment Trastuzumab Deruxtecan

Molcure and Boehringer Ingelheim Join for AI Antibody Research

Therapeutic monoclonal antibodies (mAbs) have become a cornerstone of modern medicine, particularly in oncology, autoimmune disorders, and infectious diseases

WHO, OneSight EssilorLuxottica Expand Vision Care in India

The OneSight EssilorLuxottica Foundation, an international leader in inclusive vision care, has partner with the World Health Organization (WHO) to expand eye health services across NITI Aayog's aspirational blocks.

Neuberg Diagnostics Launches Wellness Hub in Chennai

Neuberg Diagnostics, has added a Wellness Centre and Processing Lab to its list of facilities in Chennai. This new Wellness Centre in Abhiramapuram was inaugurated by Dr. Sengottuvelu G, Senior Consultant and Interventional Cardiologist at Apollo

Biocon, Carnegie Get USFDA Nod for Rifaximin IBS-D Tablets

Biocon Pharma Limited which is its fully controlled subsidiary along with Carnegie Pharmaceuticals LLC has been given approval by the US Food and Drug Administration (USFDA) to file the Abbreviated New Drug Application

Roche & KlinRisk Receive CE Mark for Kidney Klinrisk Algorithm

Roche and KlinRisk have announced that they received a CE mark for the Kidney Klinrisk Algorithm, the first AI-based risk stratification tool for determining progressive decline in kidney function. The CE mark for the Kidney Klinrisk Algorithm...

on the deck

Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.